Published in Catheter Cardiovasc Interv on March 08, 2011
Update on anti-coagulation in atrial fibrillation. QJM (2011) 1.28
Uncommon delayed and late complications after percutaneous left atrial appendage closure with Amplatzer(®) Cardiac Plug. Clin Res Cardiol (2013) 1.12
Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update. Open Heart (2014) 1.06
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Clin Res Cardiol (2015) 1.05
Thromboembolic stroke after cardioversion with incomplete left atrial appendage closure. Clin Res Cardiol (2014) 0.97
Anatomical analysis of the left atrial appendage using segmented, three-dimensional cardiac CT: a comparison of patients with paroxysmal and persistent forms of atrial fibrillation. J Interv Card Electrophysiol (2011) 0.94
Left atrial appendage closure to prevent stroke in patients with atrial fibrillation. Circulation (2014) 0.88
Minimally invasive surgical therapies for atrial fibrillation. ISRN Cardiol (2012) 0.87
Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation. Nat Rev Cardiol (2013) 0.86
Early experience using a left atrial appendage occlusion device in patients with atrial fibrillation. Yonsei Med J (2012) 0.84
Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives. J Thorac Dis (2015) 0.82
Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillation. Curr Cardiol Rev (2012) 0.81
Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review. Cardiovasc Ultrasound (2012) 0.79
Non-pharmacological therapy for atrial fibrillation: managing the left atrial appendage. Cardiol Res Pract (2012) 0.79
Left atrial appendage closure devices. Clin Med Insights Cardiol (2014) 0.78
Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? J Am Heart Assoc (2014) 0.78
Left atrial appendage exclusion for stroke prevention in atrial fibrillation. Cardiol Res Pract (2012) 0.78
Stroke prevention in nonvalvular atrial fibrillation. Tex Heart Inst J (2011) 0.77
Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage. Neurology (2013) 0.77
Left Atrial Appendage Ligation and Exclusion Technology in the Incubator. J Atr Fibrillation (2015) 0.76
Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials. Med Devices (Auckl) (2015) 0.76
Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience. Cardiovasc J Afr (2013) 0.76
Implantation of the AMPLATZER™ Cardiac Plug: tips and tricks. Herzschrittmacherther Elektrophysiol (2013) 0.76
Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care. Heart Lung Vessel (2014) 0.76
Percutaneous left atrial appendage closure-An alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia? Cardiovasc Diagn Ther (2015) 0.76
How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion. Postepy Kardiol Interwencyjnej (2015) 0.76
Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation. Methodist Debakey Cardiovasc J (2015) 0.75
The LAA occlusion Foxtrot: steps forward; steps back. Catheter Cardiovasc Interv (2011) 0.75
Optimization Of Stroke Prophylaxis Strategies In Nonvalvular AF -Drugs, Devices Or Both? J Atr Fibrillation (2015) 0.75
Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation. BMC Cardiovasc Disord (2016) 0.75
Percutaneous elimination of the left atrial appendage in quest for effective and safe prevention of stroke in patients with atrial fibrillation. Postepy Kardiol Interwencyjnej (2014) 0.75
Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device. Vasc Health Risk Manag (2017) 0.75
Medical management of connector pin thrombosis with the Amplatzer cardiac plug left atrial closure device. World J Cardiol (2013) 0.75
Successful Left Atrial Appendage Occlusion with the New Generation Amulet® Device after Late-Occurring Embolization of an Amplatzer® Cardiac Plug in a Patient with Repetitive Strokes. Case Rep Cardiol (2016) 0.75
Left atrial appendage exclusion for atrial fibrillation. Cardiol Clin (2014) 0.75
Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy. Postepy Kardiol Interwencyjnej (2015) 0.75
Cardiac Plug I and Amulet Devices: Left Atrial Appendage Closure for Stroke Prophylaxis in Atrial Fibrillation. J Atr Fibrillation (2015) 0.75
Left Atrial Appendage (LAA) Closure-Device Disengagement as a Serious Complication and How it Can Be Easily Removed. Balkan Med J (2012) 0.75
The New 3D Printed Left Atrial Appendage Closure with a Novel Holdfast Device: A Pre-Clinical Feasibility Animal Study. PLoS One (2016) 0.75
A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation. Medicine (Baltimore) (2016) 0.75
Percutaneous left atrial appendage occlusion - treatment outcomes and 6 months of follow-up - a single-center experience. Kardiochir Torakochirurgia Pol (2016) 0.75
Complications From Left Atrial Appendage Exclusion Devices. J Atr Fibrillation (2014) 0.75
Atrial fibrillation ablation and left appendage closure in heart failure patients. Curr Opin Cardiol (2015) 0.75
Left Atrial Appendage Closure Devices For Stroke Prevention. Arrhythm Electrophysiol Rev (2014) 0.75
Optimization of Stroke Prophylaxis Strategies in Nonvalvular AF - Drugs, Devices or Both? J Atr Fibrillation (2016) 0.75
Left Atrial Appendage Ligation And Exclusion Technology In The Incubator. J Atr Fibrillation (2015) 0.75
Rotational method simplifies 3-dimensional measurement of left atrial appendage dimensions during transesophageal echocardiography. Cardiovasc Ultrasound (2016) 0.75
Left atrial appendage closure: outcomes and challenges. Neth Heart J (2016) 0.75
Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation, Second Thoughts? Cardiol Res (2012) 0.75
Transcatheter closure of the left atrial appendage: initial experience with the WATCHMAN device. Int J Clin Exp Med (2015) 0.75
Left atrial appendage exclusion for atrial fibrillation: does the protection from stroke prevail in the long-term? J Thorac Dis (2016) 0.75
Pulmonary artery perforation and coronary air embolism-two fatal outcomes in percutaneous left atrial appendage occlusion. Int J Legal Med (2016) 0.75
Percutaneous management of periprocedural cardiac perforation during left atrial appendage closure. Clin Res Cardiol (2015) 0.75
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. J Arrhythm (2017) 0.75
[Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation]. Herz (2010) 0.75
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (2007) 7.61
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77
Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol (2004) 5.44
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 4.94
Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol (2005) 4.05
Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation (2011) 3.63
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med (2005) 3.60
Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation (2007) 3.40
Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv (2012) 3.32
Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J (2010) 3.26
Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol (2006) 3.07
Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation (2003) 2.97
Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol (2013) 2.97
Does the presence of accessory renal arteries affect the efficacy of renal denervation? JACC Cardiovasc Interv (2013) 2.90
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial. Lancet (2013) 2.81
[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Rev Esp Cardiol (2006) 2.63
In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention (2011) 2.63
Electrocardiographic changes of ST-elevation myocardial infarction in patients with complete occlusion of the left main trunk without collateral circulation: differential diagnosis and clinical considerations. J Electrocardiol (2012) 2.63
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol (2005) 2.47
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol (2005) 2.47
Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation (2009) 2.47
Role of microRNAs in cardiac remodelling: new insights and future perspectives. Int J Cardiol (2012) 2.32
Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol (2004) 2.30
Comparison of hospital episode statistics and central cardiac audit database in public reporting of congenital heart surgery mortality. BMJ (2007) 2.28
Paravalvular leak closure after transcatheter aortic valve replacement with a self-expanding prosthesis. Catheter Cardiovasc Interv (2013) 2.25
Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J (2012) 2.22
Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol (2005) 2.19
Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation (2012) 2.17
Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol (2010) 2.16
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet (2012) 2.14
Collateral-flow measurements in humans by myocardial contrast echocardiography: validation of coronary pressure-derived collateral-flow assessment. Eur Heart J (2005) 2.12
25 years of coronary angioplasty: almost a fairy tale. Lancet (2003) 2.09
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ (2008) 2.09
New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv (2009) 2.08
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv (2012) 2.07
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA (2006) 2.06
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation (2013) 2.03
Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther (2005) 2.03
Clinical relevance of coronary angiography at the time of percutaneous closure of a patent foramen ovale. Catheter Cardiovasc Interv (2007) 2.03
Is alcohol ablation of the septum associated with recurrent tachyarrhythmias? Swiss Med Wkly (2007) 2.01
[GISE/AIAC position paper on percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: recommendations for patient selection, facilities, competences, organizing and training requirements]. G Ital Cardiol (Rome) (2014) 1.98
Renal denervation. Anadolu Kardiyol Derg (2014) 1.96
Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail (2011) 1.92
Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease. J Am Coll Cardiol (2002) 1.92
Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation (2007) 1.90
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J (2013) 1.90
Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J (2007) 1.89
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol (2008) 1.89
Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol (2011) 1.86
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol (2008) 1.84
Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation (2003) 1.83
Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol (2013) 1.82
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J (2005) 1.81
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol (2007) 1.81
Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J (2008) 1.75
Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol. Eur Heart J (2004) 1.73
Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else! Circulation (2008) 1.72
A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol (2006) 1.72
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol (2013) 1.72
Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol (2005) 1.71
Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol (2010) 1.71
Classification of coronary artery bifurcation lesions and treatments: time for a consensus! Catheter Cardiovasc Interv (2008) 1.70
Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J (2013) 1.70
Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol (2008) 1.69
Pulmonary-artery dissection in patients with Eisenmenger's syndrome. N Engl J Med (2007) 1.69
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol (2011) 1.67
Diagnostic value of magnetocardiography in coronary artery disease and cardiac arrhythmias: a review of clinical data. Int J Cardiol (2013) 1.64
European Registry of Carotid Artery Stenting: results from a prospective registry of eight high volume EUROPEAN institutions. Catheter Cardiovasc Interv (2012) 1.61
Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. Alcohol Clin Exp Res (2005) 1.59
Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheter Cardiovasc Interv (2013) 1.59
Percutaneous coronary interventions in Europe 1992-2001. Eur Heart J (2004) 1.58
[Clinical utilization of the coronary pressure wire]. Rev Esp Cardiol (2002) 1.56
Late coronary stent thrombosis. Circulation (2007) 1.54
Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog (2013) 1.54
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol (2007) 1.54
Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg (2004) 1.54
One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther (2009) 1.53
Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. Eur Heart J (2012) 1.52
The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects. J Invasive Cardiol (2010) 1.51
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv (2012) 1.49
Red blood cell distribution width adds prognostic value for outpatients with chronic heart failure. Rev Esp Cardiol (Engl Ed) (2012) 1.49
Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. JACC Cardiovasc Interv (2012) 1.49
Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv (2007) 1.48
Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study. J Am Coll Cardiol (2005) 1.48
Transient apical ballooning syndrome--clinical characteristics, ballooning pattern, and long-term follow-up in a Swiss population. Int J Cardiol (2008) 1.48
Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment. Catheter Cardiovasc Interv (2009) 1.47